GSK promises ‘bubble boy’ gene therapy will not break the bank as new pricing model revealed
GlaxoSmithKline ($GSK) has only just received a thumbs-up from a European Medicines Agency committee for its groundbreaking new gene therapy treatment--but it's alrea...